```html

Meclizine Overdose – Comprehensive Medical Guide

Overview

Meclizine is an over‑the‑counter (OTC) antihistamine commonly used to treat motion sickness, vertigo, and nausea. It works by blocking histamine receptors in the brain, which helps reduce the sensation of dizziness.

Although meclizine is generally safe at recommended doses (typically 25–50 mg once daily for adults), taking too much can lead to an overdose. Overdose may occur accidentally—e.g., taking several tablets at once—or intentionally, and it can affect anyone who has access to the medication, from children who find a bottle left on a counter to older adults who self‑medicate without clear guidance.

Exact prevalence data for meclizine overdose are limited, but the CDC’s National Poison Data System reports that antihistamines, as a class, account for roughly 3–4 % of all reported medication overdoses in the United States each year, with meclizine representing a small but notable proportion of those cases.

Symptoms

The clinical picture of a meclizine overdose depends on the amount ingested, the patient’s age, weight, and whether other substances were taken simultaneously. Common symptoms include:

• Drowsiness or profound sedation – patients may be difficult to arouse.
• Confusion or disorientation – especially in the elderly.
• Dry mouth, blurred vision, and dilated pupils (mydriasis) – classic anticholinergic effects.
• Rapid heart rate (tachycardia) or irregular heartbeat – can progress to arrhythmias.
• Urinary retention – difficulty starting or sustaining urination.
• Constipation – slowed gastrointestinal motility.
• Hallucinations or delirium – more common with very high doses.
• Seizures – rare but reported in massive ingestions.
• Respiratory depression – slowed breathing, particularly when combined with alcohol or CNS depressants.
• Hypotension – low blood pressure causing dizziness or fainting.

Symptoms usually appear within 30 minutes to 2 hours after ingestion because meclizine reaches peak plasma concentrations in that window.

Causes and Risk Factors

What Causes an Overdose?

• Accidental ingestion – Children swallowing tablets, or adults forgetting they have already taken a dose.
• Intentional misuse – Some individuals may take large amounts hoping for a sedative or “high” effect.
• Poly‑drug interactions – Combining meclizine with alcohol, benzodiazepines, opioids, or other antihistamines magnifies CNS depression.
• Renal or hepatic impairment – Reduced clearance can cause drug accumulation even at standard doses.

Who Is at Higher Risk?

• Children under 6 years of age (small body mass → higher relative dose).
• Elderly patients, especially those with dementia or polypharmacy.
• Individuals with pre‑existing heart rhythm disorders.
• Patients with chronic kidney disease or liver disease.
• People who regularly consume alcohol or use other CNS depressants.

Diagnosis

Diagnosis of meclizine overdose is primarily clinical, based on history and physical examination. The following steps are usually taken:

1. History Taking

• Exact amount and time of ingestion.
• Co‑ingested substances (alcohol, medications, illicit drugs).
• Medical history (renal/hepatic disease, cardiac conditions, psychiatric disorders).

2. Physical Examination

• Level of consciousness (using the Glasgow Coma Scale).
• Vital signs: heart rate, blood pressure, respiratory rate, oxygen saturation.
• Signs of anticholinergic toxicity: dry mucous membranes, flushed skin, mydriasis.

3. Laboratory Tests

• Serum meclizine level – rarely measured, but can confirm exposure in research settings.
• Basic metabolic panel (electrolytes, glucose, kidney function).
• Liver function tests.
• Serum drug screen if co‑ingestants are suspected.
• Electrocardiogram (ECG) – to check for QT prolongation or arrhythmias.

4. Imaging (if indicated)

• Chest X‑ray or CT if respiratory depression raises concern for aspiration.
• Head CT only if there is concern for trauma or intracranial bleed unrelated to the overdose.

Treatment Options

Management focuses on stabilizing the patient, limiting further absorption, and addressing specific symptoms.

1. Supportive Care

• Airway, Breathing, Circulation (ABCs) – Ensure airway patency; administer supplemental O₂ if SpO₂ < 94 %.
• Place the patient on cardiac monitoring for tachyarrhythmias.
• Intravenous (IV) access with normal saline for hydration and blood pressure support.

2. Decontamination

• Activated charcoal – 1 g/kg orally within 1–2 hours of ingestion can bind meclizine and reduce systemic absorption (per Mayo Clinic).
• Gastric lavage is rarely indicated and only considered if the patient presents within 1 hour of a massive ingestion and is intubated.

3. Symptom‑Specific Interventions

• Severe sedation or seizures – Use benzodiazepines (e.g., lorazepam) for seizure control.
• Bradycardia or hypotension – Treat with IV fluids; consider atropine if symptomatic bradycardia develops.
• Arrhythmias – Follow ACLS guidelines; magnesium sulfate may be used for torsades de pointes.
• Anticholinergic toxicity (dry mouth, urinary retention) – Consider a dose of physostigmine under cardiac monitoring, but only after ruling out contraindications.

4. Observation

Most patients improve within 24 hours after supportive care. Those with moderate to severe symptoms should be observed in an emergency department or monitored admission unit for at least 12–24 hours.

5. Discharge Planning

• Education on proper dosing.
• Prescription of a limited supply if continued therapy is needed.
• Referral to primary care or cardiology if heart rhythm abnormalities persisted.

Living with Meclizine Overdose

While an overdose is an acute event, the experience can influence long‑term health behaviors. Below are practical tips for anyone who has experienced an overdose or is at risk:

• Medication Log – Keep a written or app‑based record of every dose taken, including date and time.
• Safe Storage – Store meclizine and all meds out of reach of children (≥ 1.5 m height) and in a locked cabinet when possible.
• Limit Alcohol – Avoid alcohol while using meclizine, as it potentiates sedation.
• Review Other Drugs – Discuss with your pharmacist or physician any other antihistamines, sleep aids, or CNS depressants you take.
• Regular Check‑ups – If you have kidney or liver disease, schedule periodic labs to monitor drug clearance.
• Escalate Care Early – At the first sign of confusion, severe dizziness, or heart palpitations, seek medical attention.

Prevention

Preventing a meclizine overdose centers on education, safe practices, and system‑level safeguards.

1. Read Labels Carefully – OTC products often contain 25 mg tablets; know the recommended maximum (usually 50 mg per day).
2. Use One Pharmacy – Consolidating prescriptions helps pharmacists spot duplicate therapy.
3. Implement Child‑Resistant Packaging – Use the caps that come with the bottle and keep them tightly closed.
4. Medication Review – Have a clinician review your medication list at least annually.
5. Educate Caregivers – Family members, especially those caring for seniors, should know the correct dose.
6. Avoid “Just in Case” Stockpiling – Keep only the amount needed for a few weeks.

Complications

If an overdose is not promptly recognized and treated, several serious complications can arise:

• Cardiac Arrhythmias – Prolonged QT interval may lead to torsades de pointes, a potentially fatal rhythm.
• Respiratory Failure – Severe CNS depression can necessitate intubation.
• Seizure‑Related Injuries – Falls or trauma during a seizure.
• Persistent Anticholinergic Toxicity – Extended delirium, especially in the elderly, can increase the risk of falls and long‑term cognitive decline.
• Renal or Hepatic Acute Injury – Rare, but high doses can exacerbate pre‑existing organ dysfunction.

When to Seek Emergency Care

---

Sources: Mayo Clinic. “Meclizine (Oral Route) Proper Use.” mayoclinic.org; CDC. National Poison Data System (NPDS) Annual Report 2022; NIH. “Antihistamine Toxicity” in MedlinePlus; WHO. “Guidelines for the Management of Acute Poisoning”; Cleveland Clinic. “Anticholinergic Toxicity.”

```